Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study was designed to determine a cutoff point for identifying insulin resistance from hyperinsulinemic-euglycemic clamp studies performed at 120 mU/m2 ⋅ min in a white population and to generate equations from routinely measured clinic and blood variables for predicting clamp-derived glucose disposal rate (GDR), i.e., insulin sensitivity. RESEARCH DESIGN AND METHODS: We assembled data from hyperinsulinemic-euglycemic clamps (120 mU/m2 ⋅ min insulin dose) performed at the Pennington Biomedical Research Center between 2001 and 2011. Subjects were divided into subjects with diabetes (n = 51) and subjects without diabetes (n = 116) by self-report and/or fasting glucose ≥126 mg/dL. RESULTS: We found that 75% of individuals with a GDR <5.6 mg/kg fat-free mass (FFM) + 17.7 ⋅ min were truly insulin resistant. Cutoff values for GDRs normalized for body weight, body surface area, or FFM were 4.9 mg/kg ⋅ min, 212.2 mg/m2 ⋅ min, and 7.3 mg/kgFFM ⋅ min, respectively. Next, we used classification tree models to predict GDR from routinely measured clinical and biochemical variables. We found that individual insulin resistance could be estimated with good sensitivity (89%) and specificity (67%) from the homeostasis model assessment of insulin resistance (HOMA-IR) >5.9 or 2.8< HOMA-IR <5.9 with HDL <51 mg/dL. CONCLUSIONS: We developed a cutoff for defining insulin resistance from hyperinsulinemic-euglycemic clamps. Moreover, we now provide classification trees for predicting insulin resistance from routinely measured clinical and biochemical markers. These findings extend the clamp from a research tool to providing a clinically meaningful message for participants in research studies, potentially providing greater opportunity for earlier recognition of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is no consensus on the definition of IR [145,146]”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“The mean rate of exogenous glucose infusion during the last 30 min was defined as the GDR (1).”
BackgroundThe use of the area under the ROC curve in the evaluation of machine learning algorithms
Bradley, A. P. (1997) · Pattern Recognition · doi:10.1016/s0031-3203(96)00142-2 · Cited by 7,217 · cited 2×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodA formula to estimate the approximate surface area if height and weight be known. 1916.
Bois, D. D., & Bois, E. F. D. (1989) · PubMed · Cited by 5,314
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Statistics review 13: receiver operating characteristic curves.
Bewick, V., Cheek, L., & Ball, J. (2004) · Critical Care · doi:10.1186/cc3000 · Cited by 818 · cited 1×
“We used a receiver-operating characteristic (ROC) curve, a plot of the sensitivity versus 1 – specificity, to display the trade-off between true positives and false positives across incremental choices of discriminating cutoff points for glucose disposal rate (9,10).”
MethodClark, L. A., & Pregibon, D. (2017) · Statistical Models in S · doi:10.1201/9780203738535-9 · Cited by 560
Cited by
Items 101–200 of 382
Salvatori, B., Linder, T., Eppel, D., Morettini, M., Burattini, L., Göbl, C. S., & Tura, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01649-8 · Cited by 27
“9 mg∙kg−1∙min−1, as derived by the clamp (the M parameter), can be assumed as cut-off for insulin resistance [73].”
BackgroundZhang, B., Lei, H., Ambler, G., Werring, D. J., Fang, S., Li, H., Chen, R., Wei, J., Chen, G., Liu, N., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103471 · Cited by 27
Yang, C., Song, Y., Wang, X., Yang, Y., Zhou, Y., Wang, D., Hou, J., & Wang, P. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14758 · Cited by 27
“5 Nevertheless, as a result of the intricate nature and large costs associated with this approach, its utilization is limited in clinical practice.”
BackgroundRad, M. R., Dabaghi, G. G., Sadri, H., Darouei, B., Amani‐Beni, R., & Mazaheri‐Tehrani, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01616-9 · Cited by 27
Dudi, P., Goyal, B., Saxena, V., Rabari, K., Mirza, A. A., Naithani, M., Kumar, T., & Goyal, R. (2019) · Journal of Laboratory Physicians · doi:10.4103/jlp.jlp_163_18 · Cited by 28
Delai, A., Gomes, P. M., Foss‐Freitas, M. C., Elías, J., Antonini, S. R. R., de Castro, M., Moreira, A. C., & Mermejo, L. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab767 · Cited by 25
Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease
Sánchez-Ceinos, J., Guzmán‐Ruiz, R., Rangel-Zúñiga, O. A., López‐Alcalá, J., Moreno-Caño, E., del Río-Moreno, M., Romero‐Cabrera, J. L., Pérez‐Martínez, P., Maymó‐Masip, E., Vendrell, J. J., et al. (2021) · eLife · doi:10.7554/elife.65996 · Cited by 28
“IFG individuals exhibited significantly higher HOMA-IR values than NG individuals and they will be referred to as insulin-resistant (IR) subjects ( Díaz-Ruiz et al., 2015 ; Tam et al., 2012 ).”
Shen, F., Lin, H. Y., Tsai, W., Kuo, I., Chen, Y.-K., Chao, Y.-L., Niu, S., Hung, C., & Chang, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1136284 · Cited by 23
“The TyG index has been widely used as an indicator of IR (23); its efficacy may be higher than that of HOMA-IR (24).”
MethodInfluentialGuevara‐Aguirre, J., Prócel, P., Guevara, C., Guevara‐Aguirre, M., Rosado, V., & Terán, E. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.08.002 · Cited by 23
“The failure of peripheral cells to respond to the protean actions of insulin is known as insulin resistance (IR) and is widely accepted that it eventually leads to hyperglycemia and diabetes [21].”
BackgroundAdiposity and Insufficient MVPA Predict Cardiometabolic Abnormalities in Adults
PETERSON, M. D., AL SNIH, S., STODDARD, J., MCCLAIN, J., & LEE, I.-M. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000212 · Cited by 22
“Tam CS, Ravussin E. Response to Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps.”
Argoty-Pantoja, A. D., Velázquez‐Cruz, R., Meneses‐León, J., Salmerón, J., & Rivera‐Paredez, B. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01925-w · Cited by 25
“The TyG index is a substitute to identify insulin resistance [9–11, 27, 28], and it has shown a strong correlation with the hyperinsulinemic-euglycemic clamp test [9], which has been considered the gold standard method for assessing insulin resistance [29].”
MethodWang, S., Zhang, X., Keerman, M., Guo, H., He, J., Maimaitijiang, R., Wang, X., Ma, R., & Guo, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1259062 · Cited by 22
Waldman, M. A., Han, J. C., Reyes-Capó, D. P., Bryant, J. C., Carson, K. A., Türkbey, B., Choyke, P. L., Naggert, J. Κ., Gahl, W. A., Marshall, J. D., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.07.010 · Cited by 22
“8 in adults [22] and > 90th centile of sex, age and body mass index (BMI)-matched controls in children [23].”
BackgroundDaily, J. W., Liu, M., & Park, S. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.09.009 · Cited by 22
Lee, S. H., Ahn, M. B., Choi, Y. J., Kim, S. K., Kim, S. H., Cho, W. K., Cho, K. S., Suh, B., & Jung, M. H. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040002.001 · Cited by 23
Zhang, F., Guan, W., Fu, Z., Zhou, L. Q., Guo, W., Ma, Y., Gong, Y., Jiang, W., Liang, H., & Zhou, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5681296 · Cited by 22
Wang, H., Chen, G., Sun, D., & Ma, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1411486 · Cited by 21
Peterson, M. D., Snih, S. A., Rexach, J. A. S., & Burant, C. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv002 · Cited by 23
“9, as recently determined and validated against hyperinsulinemic-euglycemic clamp by Tam and colleagues (32).”
MethodBantle, A., Lau, K. J., Wang, Q., Malaeb, S., Harindhanavudhi, T., Manoogian, E. N. C., Panda, S., Mashek, D. G., & Chow, L. S. (2022) · Obesity · doi:10.1002/oby.23620 · Cited by 21
“Although insulin clamp studies are considered the gold standard for assessing insulin sensitivity and β-cell function, they are labor-intensive and costly to perform [28], and they were not included in the clinical trial [8].”
BackgroundKim, A. H., Son, D., & Lee, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1308265 · Cited by 19
“Receiver operating characteristics (ROC) curves for each parameter in predicting MAFLD (A) in all participants, (B) in men only, and (C) in women only. standard is the hyperinsulinemic-euglycemic clamp method, but it is rarely used in clinical settings due to high cost and low accessibility (22).”
MethodKAHL, S., Nowotny, B., Piepel, S., Nowotny, P., Straßburger, K., Herder, C., Pacini, G., & Roden, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3328-3 · Cited by 19
“3 mg kg FFM min as a cut-off value for insulin resistance [40].”
BackgroundMethodVisser, S. A. G., Kandala, B., Fancourt, C., Krug, A. W., & Cho, C. R. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1729 · Cited by 19
Frazier, D. T., Bettcher, B. M., Dutt, S., Patel, N., Mungas, D., Miller, J., Green, R., & Kramer, J. H. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715000624 · Cited by 21
“While this measurement has been commonly used throughout research to approximate IR, it lacks the accuracy provided by the euglycemic clamp protocol, which directly measures both insulin sensitivity and glucose metabolic efficiency (Tam et al., 2012).”
MethodSzosland, K., & Lewiñski, A. (2015) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2015.10.007 · Cited by 21
Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes Risk
Liu, Y., Smith, C. E., Parnell, L. D., Lee, Y., An, P., Straka, R. J., Tiwari, H. K., Wood, A. C., Kabagambe, E. K., Hidalgo, B., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa072 · Cited by 18
Zhou, Y., Li, T., Muheiyati, G., Duan, Y., Xiao, S., Gao, Y., Tao, N., & An, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280221 · Cited by 18
Shekarian, A., Mazaheri‐Tehrani, S., Shekarian, S., Pourbazargan, M., Setudeh, M., Abhari, A. P., Fakhrolmobasheri, M., & Heidarpour, M. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01896-2 · Cited by 23
“Although the hyperinsulinemic-euglycemic clamp is the gold standard for detecting insulin resistance, its complex procedure limits its use in practice [70].”
KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
Xu, C., Messina, A., Somm, E., Miraoui, H., Kinnunen, T. K., Acierno, J. S., Niederländer, N. J., Bouilly, J., Dwyer, A. A., Sidis, Y., et al. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.7.11 · Cited by 18
Increased β-Cell Responsivity Independent of Insulin Sensitivity in Healthy African American Adults
Armiyaw, L., Sarcone, C., Fosam, A. E., & Muniyappa, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa234 · Cited by 18
Ye, J., Ye, X., Jiang, W., Lu, C., Geng, X., Zhao, C., Ma, Y., Yang, P., Lam, S. M., Shui, G., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108699 · Cited by 19
Dehghan, R., Saidijam, M., Mehdizade, M., Shabab, N., Yavangi, M., & Artimani, T. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0468-y · Cited by 19
Prognostic Significance of Insulin Resistance in Pulmonary Hypertension
Zare, E., Kafshbani, P., Chenaghlou, M., Noori, M., Ghaemmaghami, Z., Amin, A., Taghavi, S., & Naderi, N. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13752 · Cited by 18
Stein, R., Koutny, F., Riedel, J., Dörr, N., Meyer, K., Colombo, M., Vogel, M., Anderwald, C. H., Blüher, M., Kieß, W., et al. (2023) · Metabolites · doi:10.3390/metabo13010100 · Cited by 19
“The gold standard for measurement of IR and insulin sensitivity (IS) is the euglycemic hyperinsulinemic clamp test [12].”
Warpechowski, J. J., Leszczyńska, P., Juchnicka, D., Olichwier, A. J., Szczerbiński, Ł., & Kretowski, A. J. (2023) · Vaccines · doi:10.3390/vaccines11071203 · Cited by 21
Mashayekhi, M., Sheng, Q., Bailin, S. S., Massier, L., Zhong, J., Shi, M., Wanjalla, C. N., Wang, T. J., Ikizler, T. A., Niswender, K. D., et al. (2024) · Obesity · doi:10.1002/oby.24064 · Cited by 18
Association of HOMA-IR Versus TyG Index with Diabetes in Individuals Without Underweight or Obesity
Kim, B., Kim, G.-M., Huh, U., Lee, J. H., & Kim, E. (2024) · Healthcare · doi:10.3390/healthcare12232458 · Cited by 22
“The hyperinsulinemic-euglycemic clamp is regarded as the gold standard to evaluate IR; however, it is a costly, labor-intensive, and time-consuming method [20,21].”
Holwerda, S. W., Reynolds, L. J., Restaino, R. M., Credeur, D. P., Leidy, H. J., Thyfault, J. P., & Fadel, P. J. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00584.2015 · Cited by 17
Kamal, M. M., Adel, A., Sayed, G. H., Ragab, S. H., & Kassem, D. H. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.004 · Cited by 17
Association of Serum Alkaline Phosphatase with the TG/HDL Ratio and TyG Index in Korean Adults
Son, D., Ha, H.-S., & Lee, Y. (2021) · Biomolecules · doi:10.3390/biom11060882 · Cited by 17
“Although the gold standard measurement for assessing insulin resistance is hyperinsulinemic-euglycemic clamp, it is rarely used in a clinical setting due to high cost, low accessibility, and low reproducibility [5].”
BackgroundFernández‐Chirino, L., Antonio‐Villa, N. E., Fermín‐Martínez, C. A., Márquez‐Salinas, A., Guerra, E. C., Vargas‐Vázquez, A., Almeda‐Valdés, P., Gómez‐Velasco, D., Viveros‐Ruiz, T. L., Rojas, R., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14673 · Cited by 17
II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
Felipe Pollak, C., Araya, V., Lanas, A., SAPUNAR, J., Arrese, M. A., Aylwin, C. G., Bezanilla, C. G., Carrasco, E., Fernando Carrasco, N., Ethel Codner, D., et al. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015000500012 · Cited by 34
Kurniawan, A. L., Hsu, C., Chao, J. C.-J., Paramastri, R., Lee, H.-A., & Jallow, A. W. (2021) · Medicina · doi:10.3390/medicina58010004 · Cited by 16
“Since the clamp technique is costly and tedious, it is no longer durable for daily clinical practice [13].”
BackgroundRetinal Neurodegeneration in Euglycemic Hyperinsulinemia, Prediabetes, and Diabetes
Ebrahimi, M., Sivaprasad, S., Thompson, P. M., & Perry, G. L. (2022) · Ophthalmic Research · doi:10.1159/000528503 · Cited by 16
Ahn, S. H., Lee, H. S., & Lee, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01820-9 · Cited by 17
Wang, J., Tang, H., Tian, J., Xie, Y., & Wu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-66881-6 · Cited by 16
“Being the gold standard for assessing IR, the high insulin-normal glucose clamp represents both an intricate and expensive method 12 , which limits its use in clinical practice 13 .”
Song, Y., Jiang, L., Han, Y., Zhang, S., & Li, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05524-w · Cited by 16
“Several methodologies are employed to evaluate insulin resistance, among which the hyperinsulinaemic–eug-lycaemic clamp test stands as the criterion standard [9].”
MethodOverton, E. T., Tebas, P., Coate, B., Ryan, R. J., Perniciaro, A., Dayaram, Y. K., Rosa, G. D. L., & Baugh, B. (2016) · HIV Clinical Trials · doi:10.1080/15284336.2016.1141468 · Cited by 16
Wang, T., Yi, Z., Tan, Y., Huang, Y., Li, T., Gao, S., Wu, Y., Zhuang, W., & Guo, S. (2024) · The EPMA Journal · doi:10.1007/s13167-024-00388-y · Cited by 15
“The hyperinsulinaemic glucose clamp (HIEC) is considered the gold standard for assessing insulin sensitivity in humans [12], but its high cost and complex procedure limit its application in clinical and epidemiologic studies.”
Płaczkowska, S., Pawlik-Sobecka, L., Kokot, I., & Piwowar, A. (2019) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/109225 · Cited by 15
“the glucose clamp test) is still referred to as the “gold standard,” and the intravenous glucose tolerance test is recommended, these methods are very rarely used because of their high onerousness for the patient [5].”
Hussain, M., Jangorbhani, M., Schuette, S. A., Considine, R. V., Chisholm, R., & Mather, K. J. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0151 · Cited by 17
“This reflects the continuous distribution of insulin sensitivity that is observed in populations and is what is typically observed with other measures of insulin sensitivity, including the clamp data presented here.(9,10) A small set of prior studies has reported that surrogate measures of insulin sensitivity are corr…”
BackgroundZeng, H., Zhang, Y., Huang, S., Wu, J., Ren, W., Zhou, L., Huang, L., & Ye, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1223768 · Cited by 19
“In addition, compared with the hyperinsulinemiceuglycemic clamp test, the gold standard of assessing insulin resistance, HOMA-IR, still has several limitations and may affect the accuracy of the study results (31).”
BackgroundYan, R., Zhang, J., Ma, H., Wu, Y., & Yang, F. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01416-w · Cited by 14
“The hyperinsulinemic-euglycemic clamp technique is considered the gold standard for assessing IR [10].”
Herrera-Ojeda, J. L., Blanco-Palma, R. S., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02621-5 · Cited by 16
“[37 ] The importance of these variables lies in the positive correlation between waist-to-hip ratio, triglyceride levels, and blood pressure, and their negative correlation with HDL levels.”
Hirasawa, Y., Matsuki, R., Ebisu, T., Kurose, T., Hamamoto, Y., & Seino, Y. (2019) · Journal of Physical Therapy Science · doi:10.1589/jpts.31.190 · Cited by 14
Intrinsic Frequency and the Single Wave Biopsy: Implications for Insulin Resistance
Petrasek, D., Pahlevan, N. M., Tavallali, P., Rinderknecht, D. G., & Gharib, M. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815588108 · Cited by 14
Tu, Y., Yu, H., Zhang, P., Di, J., Han, X., Wu, S.-H., Bao, Y., & Jia, W. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12200 · Cited by 16
Deng, M., Song, K., Xu, W., He, G., Hu, J., Xiao, H., Zhou, N., Chen, S., Xu, G., Tong, Y., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1421655 · Cited by 13
Zhu, H., Chen, Y., Ding, D., & Chen, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1427727 · Cited by 13
Mi, W., Hao, Y., Wan, M.-G., Zhang, J., Huang, H., Song, C.-Z., He, Q., Fan, N.-Y., Yao, X. X., & Chen, C.-Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-08133-9 · Cited by 13
Koutny, F., Stein, R., Kieß, W., Weghuber, D., & Körner, A. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12822 · Cited by 13
Meza, C. A., Amador, M., McAinch, A. J., Begum, K., Roy, S., & Bajpeyi, S. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-04886-7 · Cited by 13
Han, K., Tan, K., Shen, J., Gu, Y., Wang, Z., He, J., Kang, L., Sun, W., Gao, L., & Gao, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1008794 · Cited by 13
“susceptible to the accuracy of insulin measurements and is poorly reproducible (37).”
BackgroundPhenotypic diversity of human adipose tissue-resident NK cells in obesity
Haugstøyl, M. E., Cornillet, M., Strand, K., Stiglund, N., Sun, D., Lawrence‐Archer, L., Hjellestad, I. D., Busch, C., Mellgren, G., Björkström, N. K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130370 · Cited by 13
“Also, HOMA-IR does not provide the same accuracy as an hyperinsulinemic-euglycemic clamp measurements, considered the gold standard of insulin resistance measurement (30).”
BackgroundVenkatesan, P., Tiwari, A., Dasgupta, R., Carey, M., Kehlenbrink, S., Wickramanayake, A., Jambugulam, M., Jeyaseelan, L., Ramanathan, K., Hawkins, M. A., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.024 · Cited by 13
Shin, D., Eom, Y. S., Chon, S., Kim, B.-J., Yu, K., & Lee, D. H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s195350 · Cited by 14
“Because the hyperinsulinemic-euglycemic clamp is time consuming, laborious and expensive, estimating insulin sensitivity through the glucose disposal rate (GDR or M-value) by the clamp study and its reference range is limited in practice, especially for high-dose insulin infusions in East Asians, including Koreans.(1)…”
BackgroundResultInfluentialYu, L., Cai, Y., Qin, R., Zhao, B., & Li, X. (2019) · Medicine · doi:10.1097/md.0000000000018265 · Cited by 13
Low-carbohydrate diet and maternal glucose metabolism in Chinese pregnant women
Chen, Q., Chen, Y., Wu, W., Tang, N., Wang, D., Chen, Y., Jin, J., & Cai, L. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520004092 · Cited by 16
“HOMA-IR is widely used to identify individuals with insulin resistance in clinical and epidemiological studies(28,29).”
MethodSikorskaya, K., Zarzecka, I., Ejikeme, U., & Russell, J. L. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100080 · Cited by 13
“With this inmind, ADA currently does not recommend usingMetformin as an adjunctive therapy to treat T1DM in overweight and obese adolescents [6].”
MethodInfluentialInsulin infusion decreases medium-sized extracellular vesicles in adults with metabolic syndrome
Heiston, E. M., Ballantyne, A. C., Stewart, N. R., Salvia, S. L., Musante, L., Lanningan, J., Erdbrügger, U., & Malin, S. K. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2022 · Cited by 13
Alperet, D. J., Rebello, S. A., Khoo, E. Y.-H., Tay, Z., Seah, S. S. Y., Tai, B., Emady‐Azar, S., Chou, C. J., Darimont, C., & van Dam, R. M. (2016) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2016.06.013 · Cited by 13
“Because the extent of glucose disposal in adipose tissues remains unclear, previous studies based on glucose clamps have typically reported insulin sensitivity measures standardized to both body weight and fat free mass [35,38].”
BackgroundMcLeod, A., Schiffer, L. A., Castellanos, K., DeMott, A., Olender, S. E., Fitzgibbon, M., Hughes, S. L., Fantuzzi, G., & Tussing-Humphreys, L. M. (2020) · Nutrients · doi:10.3390/nu12113299 · Cited by 15
“It was not measured with the hyperinsulinemic-euglycemic clamp, which is the gold standard [71].”
MethodThe Biosimilar Insulin Landscape: Current Developments
Lavalle-Gonzalez, F. J., & Khatami, H. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.10.2823 · Cited by 12
Wani, K., Khattak, M. N. K., Saadawy, G. M., Al-Attas, O. S., Alokail, M. S., & Al‐Daghri, N. M. (2023) · Diagnostics · doi:10.3390/diagnostics13020324 · Cited by 11
“The euglycemic hyperinsulinemic clamp test has been a gold standard for over four decades and is a direct method for estimation of IR; however, it is labor-intensive, impractical and uncomfortable for the patient [18].”
MethodChoksi, H., Pleass, H. C. C., Robertson, P. R., Au, E. H. K., & Rogers, N. M. (2025) · Transplantation · doi:10.1097/tp.0000000000005334 · Cited by 13
Fu, C., Li, Y., Gao, X., Gong, Y., Wang, H., Wang, G., Ma, X., Han, B., Liu, S., Zhang, H., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01636-5 · Cited by 11
Lang, Y., Song, X., Chen, Y., Mei, H., Wu, C., Zhang, R., & Xue, C. (2025) · BMC Oral Health · doi:10.1186/s12903-025-05752-6 · Cited by 11
“The hyperinsuline-mic–euglycemic clamp is the gold standard for evaluating IR [45].”
Chai, S., Zhang, R., Ning, Z., Zheng, Y.-M., Rajpathak, S. N., & Ji, L. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.107335 · Cited by 12
Underrated enemy – from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract
Derra, A., Bator, M., Menżyk, T., & Kukla, M. (2018) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2018.75955 · Cited by 11
“The definition of IR assumes that it is a state which requires higher-than-normal insulin concentrations to obtain suitable biological effects [17, 18].”
BackgroundKoopen, A. M., de Clercq, N. C., Warmbrunn, M. V., Herrema, H., Davids, M., de Groot, P. F., Kootte, R. S., Bouter, K. E. C., Nieuwdorp, M., Groen, A. K., et al. (2020) · Nutrients · doi:10.3390/nu12082308 · Cited by 13
“is the current gold standard method to assess EGPsupp and the rate of glucose disappearance (Rd), reflecting hepatic and peripheral insulin resistance, respectively [17,18].”
MethodBillingsley, H. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3633 · Cited by 11
“Additionally, participants underwent a hyper ‐ insulinemic euglycemic clamp, the gold standard method for assessing insulin resistance, 53 where no differences were demonstrated between control and cADF phases.”
MethodAssociation between triglyceride glucose-waist height ratio and stroke: a population-based study
Xu, F., Su, X., Dai, F., Ye, Y., Hu, P., & Cheng, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1510493 · Cited by 12
Jiang, W.-Z., Fan, Z., Xu, M.-L., Qian, E.-H., & Lu, K.-D. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00878-3 · Cited by 11
Anderwald, C. H., Tura, A., Gessl, A., Smajis, S., Bieglmayer, C., Marculescu, R., Luger, A., Pacini, G., & Krebs, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115184 · Cited by 11
“[18], since acromegalics with insulin resistance seem most prone for developing type-2 diabetes.”
BackgroundRoth, C. L., Elfers, C., & Hampe, C. S. (2017) · Nutrition and Diabetes · doi:10.1038/s41387-017-0004-y · Cited by 12
Estimation of metabolic factors related to insulin resistance and metabolic syndrome in young people
Płaczkowska, S., Pawlik-Sobecka, L., Kokot, I., & Piwowar, A. (2018) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1469787 · Cited by 11
“Currently, the ‘gold standard’ for the identification of insulin resistance is the metabolic clamp method, but it is invasive, very stressful and may be harmful to patients [11].”
BackgroundGutaj, P., Zawiejska, A., Brązert, J., & Wender-Ożegowska, E. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.2830 · Cited by 13
Oza, C. M., Khadilkar, A. V., Karguppikar, M. B., Gondhalekar, K. M., & Khadilkar, V. V. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0076 · Cited by 11
Rebello, C. J., Beyl, R. A., Greenway, F. L., Atteberry, K. C., Hoddy, K. K., & Kirwan, J. P. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2022.0072 · Cited by 11
“31,32 These baseline concentrations may explain why there was no change in the AUC for glucose, but the AUC for insulin and HOMA-IR were reduced.”
Bauer, I., Rimbach, G. H., Cordeiro, S., Bosy‐Westphal, A., Weghuber, J., Ipharraguerre, I. R., & Lüersen, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396292 · Cited by 10
Wrench, E., Subar, D. A., Bampouras, T. M., Lauder, R. M., & Gaffney, C. J. (2024) · Experimental Physiology · doi:10.1113/ep091433 · Cited by 11
“To allow for the less invasive collection of arterialised distal blood samples, participants can place their hand in a heated box ( ∼ 41 ◦ C; Tam et al., 2012) for ∼ 15 min prior to samples being taken and between sampling, to allow for arterialisation of the blood via arterial–venous shunting…”
BackgroundInfluentialHe, Z., Xu, M., Yang, J., & Xu, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316581 · Cited by 10
He, R., Sun, H., Liu, H., & Li, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1648823 · Cited by 11
“The hyperinsulinaemic-euglycaemic clamp (HEC) remains the gold standard for assessing insulin resistance (IR) (8).”
Yuan, R., Zhao, Y., Yuan, H., Tang, S., Feng, S., Yang, C., Wang, X. Q., Ding, F., & Zhang, R. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03073-0 · Cited by 10
“Traditional methods for assessing IR, including the hyperinsulinemic-euglycemic clamp and the homeostasis model assessment for insulin resistance (HOMA-IR), are limited by cost, complexity, and interference from insulin therapy [10, 11].”
Wang, X., Yan, H. Y., Zhong, W., Xie, J., Chen, H., Wang, J., Song, W., Shen, D., Zhang, P., Zhang, X., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70536 · Cited by 10
“9,10 As a result, several surrogate indices of IR, including estimated glucose disposal rate (eGDR), triglyceride-glucose (TyG) index, metabolic score for insulin resistance (METS-IR), and lipid accumulation product (LAP), have been developed based on readily available laboratory and anthropometric…”
Halama, A., Suleiman, N., Kuliński, M., Bettahi, I., Hassoun, S., Alkasem, M., Abdalhakam, I., Iskandarani, A., Samra, T. A., Atkin, S. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73723-8 · Cited by 11
“The subjects enrolled for the study underwent (1) an initial screening that included clinical examination and fasting blood analysis for electrolytes, glucose, liver enzymes, lipid profile, complete blood count (CBC) and thyroid-stimulating hormone (TSH), urinalysis, and electrocardiogram (ECG); (2) a 75 g oral glucos…”
BackgroundMethodImpact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity
Ketterl, T. G., Chow, E. J., Koves, I. H., Goodman, P., Leisenring, W. M., Ballard, S., Dengel, D. R., Moran, A., Sinaiko, A. R., Steinberger, J., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.10.026 · Cited by 10
The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes
Mertens, J., Roosens, L., Braspenning, R., Vandebeeck, J., Francque, S., & Block, C. E. M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae175 · Cited by 10
Ciardullo, S., Dodesini, A. R., Lepore, G., Corsi, A., Scaranna, C., Perseghin, G., & Trevisan, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad682 · Cited by 9
Voziki, D., Dimakopoulos, G., Stergiou, I., Zografou, I., Rizzo, M., Liberopoulos, E. N., Kotsa, K., & Koufakis, T. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109044 · Cited by 9
Liu, H., Meng, C., Wang, Z., Liu, C., Yu, C.-H., & Li, Z. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432049 · Cited by 9
“12 13–16 Recently, some researchers have demonstrated that the modified TyG indices, including TyG-waist circumference (TyG-WC), TyG-body mass index (TyG-BMI) and TyG-waist to height ratio (TyG-WHtR), exhibited higher predictability of IR than TyG index alone.”
Background
Metadata
- Authors
- Tam, C. S., Xie, W., Johnson, W. D., Cefalu, W. T., Redman, L. M., & Ravussin, E.
- Affiliations
- Pennington Biomedical Research Center (US)
- Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-06-12
- Volume
- 35
- Issue
- 7
- Pages
- 1605-1610
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3379600
- OpenAlex
- W2144789811
- Semantic Scholar
- 305e825690957f04df3471db275d0357f65dc523
- Cited by
- 364
- References
- 17
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 51 · 2023: 43 · 2022: 37 · 2021: 25 · 2020: 23 · 2019: 17 · 2018: 17 · 2017: 6 · 2016: 12 · 2015: 19 · 2014: 13 · 2013: 11 · 2012: 4
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060412, U01DK094418, P30DK072476)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R00HD060762)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin resistance, hyperinsulinemic-euglycemic clamp, glucose disposal rate, insulin sensitivity, cut-off values, HOMA-IR, HDL cholesterol, classification trees, diabetes mellitus, fat-free mass
- MeSH terms
- Adult, Aged, Decision Trees, Humans, Insulin, Insulin Resistance, Middle Aged, Models, Biological, Reference Values, Glucose Clamp Technique, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.